发明名称 PHTHALIMIDE DERIVATIVE AND MEDICINE CONTAINING THE DERIVATIVE
摘要 <p>PROBLEM TO BE SOLVED: To obtain the subject new compound having activities for selectively suppressing the production of IgE and IL-5, capable of manifesting activities in the immediate and chronic allergy, and becoming an active ingredient of antiallergic agent. SOLUTION: The subject compound is a phthalimide derivative of the formula [R<1> to R<4> are each H, hydroxy group, a lower alkyl, carbamoyl, amino, nitro, etc.; A is N atom, etc.; B is H, a lower alkyl, a cycloalkyl, an aryl, etc.; X is 1-4C alkylene, etc.; Y is O atom, S atom, etc.; Z is a 1-4C alkylene, a 2-4C alkenylene, etc.; (l), (m) and (n) are each independently 0 or 1; Cy is an aryl, a heterocyclic group, etc.] or a pharmaceutically acceptable salt thereof. For example, 2-[(S) -2-benzyloxy -1-phenylethyl] -2,3-dihydro -1,3-dioxo -1H -isoindole -5-carboxylic acid is cited. An antiallergic agent having both effectiveness and safety is provide by using the compound of the formula as an active ingredient.</p>
申请公布号 JPH1135559(A) 申请公布日期 1999.02.09
申请号 JP19980153777 申请日期 1998.05.19
申请人 JAPAN TOBACCO INC 发明人 KAWASAKI HISASHI;SHINAGAWA TAKENORI;MIMURA TAKAYUKI
分类号 C07D401/04;A61K31/00;A61K31/40;A61K31/403;A61K31/4035;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/445;A61K31/535;A61P11/00;A61P17/00;A61P37/00;A61P37/08;A61P43/00;C07D209/48;C07D401/06;C07D401/12;C07D405/12;C07D409/06;(IPC1-7):C07D209/48 主分类号 C07D401/04
代理机构 代理人
主权项
地址